Related Experiment Videos
AngioJet thrombectomy
Michael S Lee1, Varinder Singh, James R Wilentz
1Division of Cardiology, St. Luke's-Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, NY 10025, USA. michaelslee@pol.net.
The Journal of Invasive Cardiology
|October 27, 2004
Summary
The AngioJet system uses rheolytic thrombectomy to effectively remove blood clots, showing favorable long-term outcomes for acute myocardial infarction patients compared to standard angioplasty.
Area of Science:
- Cardiovascular Medicine
- Medical Devices
- Interventional Cardiology
Background:
- Thrombus formation is a critical factor in acute myocardial infarction (AMI) and saphenous vein graft (SVG) degeneration.
- Effective thrombus removal is essential for improving patient outcomes in cardiovascular interventions.
Purpose of the Study:
- To evaluate the efficacy of the AngioJet rheolytic thrombectomy system in reducing thrombus burden.
- To compare long-term outcomes of rheolytic thrombectomy with conventional primary angioplasty in AMI patients.
Main Methods:
- Utilized the AngioJet system employing the Venturi-Bernoulli effect with high-velocity saline jets.
- Assessed thrombus burden reduction in patients with AMI and degenerated SVGs.
Main Results:
- The AngioJet system effectively reduces thrombus burden in cases of AMI and degenerated SVGs.
- Long-term follow-up indicates favorable outcomes for patients treated with rheolytic thrombectomy for AMI compared to primary angioplasty.
Conclusions:
- Rheolytic thrombectomy with the AngioJet catheter is a viable option for thrombus removal in specific cardiovascular conditions.
- Favorable long-term results suggest potential advantages over conventional angioplasty for AMI treatment.